This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by López-Urrutia, L.
Right arrow Articles by Sánchez Crespo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by López-Urrutia, L.
Right arrow Articles by Sánchez Crespo, M.

 Previous Article  |  Next Article 

Infection and Immunity, March 2000, p. 1740-1745, Vol. 68, No. 3
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Lipopolysaccharides of Brucella abortus and Brucella melitensis Induce Nitric Oxide Synthesis in Rat Peritoneal Macrophages

Luis López-Urrutia,1,2 Andrés Alonso,3 Maria Luisa Nieto,2 Yolanda Bayón,3 Antonio Orduña,1,2 and Mariano Sánchez Crespo3,*

Departamento de Microbiología, Facultad de Medicina,1 Unidad de Investigación, Hospital Clínico Universitario,2 and Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Cientificas,3 Valladolid, Spain

Received 28 October 1999/Returned for modification 16 November 1999/Accepted 6 December 1999


    ABSTRACT
Top
Abstract
Text
References

Smooth lipopolysaccharide (S-LPS) and lipid A of Brucella abortus and Brucella melitensis induced the production of nitric oxide (NO) by rat adherent peritoneal cells, but they induced lower levels of production of NO than Escherichia coli LPS. The participation of the inducible isoform of NO synthase (iNOS) was confirmed by the finding of an increased expression of both iNOS mRNA and iNOS protein. These observations might help to explain (i) the acute outcome of Brucella infection in rodents, (ii) the low frequency of septic shock in human brucellosis, and (iii) the prolonged intracellular survival of Brucella in humans.


    TEXT
Top
Abstract
Text
References

Members of the genus Brucella are gram-negative bacteria that produce chronic infections in a large number of mammals, including humans (10). Brucella species are facultative intracellular pathogens which survive within a variety of cells, including macrophages, and the virulence of these species and the establishment of chronic infections by them are thought to be essentially due to their ability to avoid the killing mechanisms within macrophages (3, 36). The molecular mechanisms accounting for these properties are incompletely understood, and only some aspects of the processes involved have been identified as yet. Brucella does not evade phagocytosis by macrophages or neutrophils (6) but inhibits the degranulation of both primary and secondary neutrophil granules (30, 33, 34) and the myeloperoxidase-hydrogen peroxide-halide system (5, 7). The virulence of Brucella abortus, Brucella melitensis, and Brucella suis is associated with the smooth colony morphotype which contains the full lipopolysaccharide (LPS) (36, 38). The low biological activity induced by Brucella smooth LPS (S-LPS) compared with that produced by enterobacterial endotoxin might be one of the factors contributing to the survival of these pathogens in phagocytic cells (32). Further, a major proportion of the protective antibody response is directed against the O-chain component of the S-LPS (11) and Brucella LPS itself is a virulent factor because it is the main cause of the resistance of Brucella to lysosomal cationic proteins (15).

Nitric oxide (NO) has been shown to play an important role in diverse functions, including vasoregulation, neurotransmission, immune response regulation (23, 24, 37), and macrophage-mediated cytotoxic activity against tumor cells and a variety of pathogens, including bacteria, fungi, viruses, helminths, and protozoa (22). NO has been implicated in host defenses against intracellular pathogens and might play a role in persistent or latent infections (14). NO is derived from L-arginine in a reaction catalyzed by the enzyme NO synthase (NOS), of which three different isoforms have been identified (29). The inducible isoform of NOS (iNOS) is responsible for the high-output path of NO production involved in antimicrobial activity (28). iNOS expression is induced by proinflammatory cytokines such as gamma interferon (IFN-gamma ), tumor necrosis factor alpha, and interleukin 1 (IL-1), as well as by microbial products such as LPS and lipoteichoic acid (14). The purpose of this study was to determine whether Brucella S-LPS induces NO production in rat peritoneal macrophages and compare the effects of S-LPS from various Brucella species with that of Escherichia coli LPS. Since most biological effects of LPS have been associated with the lipid A moiety (25), we also investigated NO induction by Brucella lipid A. We report that B. abortus and B. melitensis S-LPS and lipid A induce NO production in rat peritoneal macrophages by a mechanism involving transcriptional up-regulation of the iNOS gene.

Pathogen-free Wistar rats (200 to 300 g) were used for all studies. B. melitensis 16M (biotype 1) and B. abortus 544 (biotype 1) smooth virulent strains were grown on Brucella broth (Difco Laboratories, Detroit, Mich.). Phenol-inactivated bacteria were harvested by centrifugation and washed twice with saline. S-LPS was extracted by the phenol-water method modified for Brucella organisms as described by Leong et al. (20), which allows the separation of Brucella S-LPS in the phenolic phase. Purification of crude S-LPS isolated in the phenolic phase was performed according to the procedure of Moreno et al. (26). The thiobarbituric method was used to measure 2-keto-3-deoxyoctonate (KDO) (2). Under these experimental conditions B. melitensis 16M purified S-LPS contained 0.79% KDO, B. abortus 544 purified S-LPS contained 0.70% KDO, and E. coli O:26,B:6 LPS (Sigma Chemical, St. Louis, Mo.) contained 1.6% KDO. Lipid A from E. coli, B. abortus, and B. melitensis was obtained by hydrolysis of purified S-LPS with 2% acetic acid at 100°C for 1 h (E. coli) or 5 h (Brucella) (25). Resident peritoneal cells were collected from the peritoneal cavity with cold phosphate-buffered saline as reported previously (4). Adherent macrophage monolayers were obtained by plating the cells in 24-well tissue culture plates at 1.5 × 106 cells/well for 2 h at 37°C. The production of NO was determined by the accumulation of nitrite measured by the Griess reaction (16). Statistical analysis was carried out using the unpaired Student t test for comparison of two means and one-way analysis of variance with the Bonferroni test for multiple comparisons of means. Statistical significance was set at a P value of <0.05.

Production of NO by rat peritoneal cells stimulated Brucella S-LPS and lipid A. Peritoneal cells stimulated with E. coli, B. abortus, and B. melitensis LPS generated nitrite in a dose-dependent manner (Fig. 1A). Since E. coli LPS is a microbial product inducing NO production by murine macrophages (39), it was included as a control of our cellular system and for comparison with Brucella S-LPS induction. E. coli LPS induced a significant level of production of NO from a dose of 0.01 µg/ml, plateau values being reached for LPS doses of >= 1 µg/ml. B. abortus S-LPS showed significant levels of NO production at doses of >0.1 µg/ml and produced maximal levels at a dose of 10 µg/ml. B. melitensis S-LPS induced NO production at concentrations higher than 0.01 µg/ml, with maximal induction at doses of >= 1 µg/ml. These data indicate that E. coli LPS is the most potent inductor of NO, whereas there was no significant difference in the NO production levels induced by B. abortus and B. melitensis S-LPS. The generation of nitrite by E. coli, B. abortus, and B. melitensis LPS was time dependent (Fig. 1B), first showing a lag of approx 8 h before significant production could be assayed and then increasing up to 24 h and showing plateau levels at 48 and 72 h (data not shown). Because most of the biological effects of the LPS have been associated with the lipid A moiety, we studied the ability of these lipids to induce NO production. Lipid A from both Brucella stimulated the production of NO in a dose-dependent manner (Fig. 1C). E. coli lipid A was again a potent inductor, significant production of NO being detected with concentrations of lipid A as low as 0.001 µg/ml, whereas maximal production was observed at a concentration of approx 0.1 µg/ml. B. abortus and B. melitensis lipid A showed similar potencies to elicit NO induction, i.e., significant amounts of nitrite were obtained in the presence of a concentration of 0.1 µg/ml and maximal production was obtained with concentrations of >= 1 µg/ml. Evidence of the involvement of the L-arginine pathway was obtained with the NOS inhibitor NG-methyl-L-arginine (L-NMA), which suppressed nitrite production induced by each LPS and lipid A (Fig. 2).


View larger version (18K):
[in this window]
[in a new window]
 
FIG. 1.   (A) Production of nitrite by rat peritoneal adherent cells stimulated with different concentrations of E. coli LPS (), B. abortus S-LPS (black-triangle), and B. melitensis S-LPS (). Adherent rat peritoneal cells were stimulated with LPS at the concentrations indicated. NO2- production was assayed 24 h after stimulation. Data are the means ± the standard errors of the means of results of four experiments with duplicate samples. (B) Kinetics of nitrite synthesis by adherent peritoneal cells stimulated with 1 µg of E. coli LPS (), B. abortus S-LPS (black-triangle), or B. melitensis S-LPS () per ml. Cells were allowed to adhere to plastic dishes and then were stimulated as indicated. Open circles indicate cells without any stimulus. Data are the means ± the standard errors of the means of results of three experiments performed in duplicate. (C) Production of nitrite by rat peritoneal adherent cells stimulated with different concentrations of E. coli (), B. abortus (black-triangle), or B. melitensis () lipid A. Nitrite production was assayed after 24 h of incubation. Data are the means ± the standard errors of the means of results of four experiments with duplicate samples. The nitrite levels induced by Brucella S-LPS and lipid A were significantly different from those of E. coli. *, P < 0.05; **, P < 0.01; ***, P < 0.001.


View larger version (33K):
[in this window]
[in a new window]
 
FIG. 2.   Effect of L-NMA on nitrite production induced by E. coli, B. abortus, and B. melitensis LPS and lipid A. Adherent cells were incubated with 1 µg of the indicated LPS (A) or lipid A (B) per ml, in the presence (solid bars) or absence (hatched bars) of 0.5 mM L-NMA. Nitrite production was assayed after 24 h. Open bars show the production by control cells. Data are the means ± the standard errors of the means of results of three experiments performed in duplicate. The nitrite levels induced in the presence of L-NMA were significantly different from those induced with only the LPS or lipid A. *, P < 0.001.

Induction of iNOS mRNA expression in adherent peritoneal cells stimulated with LPS and lipid A. To address the involvement of iNOS in response to Brucella S-LPS the expression of iNOS mRNA was studied by Northern blot analysis. For this purpose, total cellular RNA was prepared from cell cultures according to the guanidium isothiocyanate method (8). Aliquots of total RNA (10 µg) were denatured and then separated by electrophoresis (35). After capillary transference of the RNA to nylon membranes, the membranes were hybridized overnight (9) with a radiolabeled DNA probe specific for mouse macrophage iNOS. The membranes were rehybridized, with 32P-labeled beta -actin probe used as an internal control to demonstrate the integrity of the RNA, the equivalence of loading, and the specificity of mRNA induction. As shown in Fig. 3, cells incubated with E. coli, B. abortus, and B. melitensis LPS showed enhanced expression of iNOS mRNA compared to cells incubated with vehicle. E. coli LPS induced an increased expression of iNOS mRNA that was already detected at 2 h and that showed a peak at 8 h and an elevation above resting levels at 24 h (Fig. 4A and B). This time course of iNOS mRNA induction closely parallels nitrite production. B. abortus S-LPS also showed a time-dependent induction of iNOS mRNA (Fig. 4C and D), with increased levels after 2 h of stimulation and a maximal expression at 4 h. Incubation with B. melitensis S-LPS also increased iNOS mRNA in a time-dependent manner (Fig. 4E and F). Nitrite production induced by lipid A also correlated with iNOS mRNA expression. As shown in Fig. 3, the addition of E. coli, B. abortus, and B. melitensis lipid A enhanced iNOS mRNA expression, thus confirming the involvement of the lipid A moiety in this biological effect. Induction of iNOS mRNA was accompanied by the expression of iNOS protein, as judged from Western blot analysis. For this purpose, cell lysates were subjected to electrophoresis on a sodium dodecyl sulfate-8% polyacrylamide gel, transferred to a nitrocellulose membrane, and then incubated with rabbit anti-mouse iNOS antibody (Calbiochem). The detection was performed using the enhanced chemiluminescence system (Amersham). Figure 5 shows the expression of iNOS protein in adherent peritoneal cells incubated with 10 µg of LPS from either class per ml.


View larger version (37K):
[in this window]
[in a new window]
 
FIG. 3.   Effect of E. coli, B. abortus, and B. melitensis LPS and lipid A on iNOS mRNA. Adherent cells were treated with 1 µg of LPS or lipid A per ml. (A) Total RNA was isolated after 24 h of stimulation and evaluated by Northern blot analysis with 32P-labeled iNOS and beta -actin DNA probes. The relative level of NOS mRNA expression was determined for each lane after normalization to the respective beta -actin signal. The iNOS signal obtained in the absence of LPS was assigned a value of 1 to allow calculation of a relative level of mRNA expression for all other treatments. (B) The histogram shows the densitometric analysis of the autoradiograph shown in panel A. This is a representative experiment of four similar ones.


View larger version (69K):
[in this window]
[in a new window]
 
FIG. 4.   Time course of iNOS mRNA induction by E. coli LPS (A and B), B. abortus S-LPS (C and D), and B. melitensis S-LPS (E and F). Total RNA was isolated at the indicated times and used for Northern blot analysis with 32P-labeled iNOS and beta -actin DNA probes. The relative level of iNOS mRNA expression was determined for each lane after normalization to the respective beta -actin signal. The iNOS signal at 0 h was assigned a value of 1 to allow calculation of a relative level of mRNA expression for all other treatments. Results of scanning densitometric analysis of the autoradiographs in panels A, C, and E are presented in the histograms of panels B, D, and E (hatched bars indicate cells incubated for 24 h in the absence of LPS). These results are representative of those from three similar experiments.


View larger version (37K):
[in this window]
[in a new window]
 
FIG. 5.   Analysis of iNOS protein in peritoneal macrophages treated with E. coli, B. abortus, and B. melitensis LPS. Adherent cells were incubated with 10 µg of LPS per ml for 24 h. Cell lysates containing 40 µg of protein were analyzed by Western blotting with a rabbit anti-mouse iNOS antibody and peroxidase-conjugated anti-rabbit immunoglobulin G. These results are representative of three experiments.

Although the connection between NO and Brucella has been addressed by using whole bacteria and compared with the effect of E. coli (17), NO induction by Brucella S-LPS has not been reported. However, it has been observed that IL-12 depletion results in a reduced production of NO by spleen cells of mice infected with Brucella, thus indicating that LPS in intact Brucella stimulates macrophages to produce IL-12 and other costimulatory cytokines (44). It has been suggested that differences in the reactivities of LPS from Brucella and E. coli could explain the discrepancies in the capacities of these bacteria to induce NO release (17). Lipid A seems to be the active portion of Brucella S-LPS molecule associated with NO production, although it is approx 100-fold less potent than E. coli lipid A, a result in agreement with the relative potency reported by Rasool et al. (32), who compared the effect of Brucella and Salmonella LPS on nitroblue tetrazolium reduction and lysozyme release by neutrophils.

Since NO is a potent vasodilator, the overproduction of which has been shown to occur during the host inflammatory response associated with septic shock (13, 31), the reduced ability of Brucella S-LPS to induce NO production could explain the low frequency of septic shock and multiorgan failure observed in brucellosis (19) and the occurrence of clinical episodes similar to those observed upon infusion of small amounts of endotoxin (40). However, before extending these results to pathophysiological conditions, it should be taken into account that peritoneal macrophages are not the only contributors to host response during endotoxin-induced injury in vivo and the in vitro approach may overlook the contribution of other major players acting in vivo (1).

Expression of iNOS mRNA in J774A.1 cells infected with B. suis has been reported; however, both iNOS protein and NO production were detected only upon treatment with IFN-gamma and antibrucella-specific antibodies (17). Since the stimulation of receptors for the Fc portion of immunoglobulin G (Fcgamma R) can induce iNOS expression in rat macrophages (4), and immune complexes of different isotypes increase nitrite levels in murine macrophage-like J774.16 cells treated with IFN-gamma (27), it seems likely that stimulation of Fcgamma R could be the mechanism accounting for the induction of iNOS under these conditions. The synergistic inductive contribution of IFN-gamma (17) agrees with the current paradigm of transcriptional regulation of iNOS. In fact, two regions have been identified in the promoter region of the mouse gene for macrophage iNOS (21): region I contains LPS-related responsive elements, including a binding site for nuclear factor-IL-6 and the kappa B binding site for activation of NF-kappa B, and region II contains motifs for binding IFN-related transcription factors such as interferon regulatory factor-1. Since NF-kappa B is involved in the induction of iNOS by LPS (43) and Fcgamma R (4), these findings show the high degree of functional cooperation between microbial components and host immune response in the induction of the transcriptional activation implicated in antimicrobial actions.

Evidence of NO-dependent antimicrobial activity by human macrophages against parasites, fungi, bacteria, and viruses is now available (41), although significant differences between murine macrophages and human monocytes or macrophages have been stressed (12). Whereas rodent macrophages respond vigorously to a combination of IFN-gamma and LPS, these stimuli induce the expression of iNOS in human cells but do not elicit any production of nitrogen derivatives, suggesting posttranslational regulation of NO synthesis in human cells (42). Addressing the effect of NO on Brucella survival seems of interest since Brucella stays alive in phagocytic cells; however, this is a controversial issue as yet. Zhan et al. (45) showed a vigorous production of NO by spleen cells of B. abortus-infected mice, compared to that of both spleen cells from noninfected mice and spleen cells from IL-12-depleted mice. When heat-killed brucellae were used as a stimulus for spleen cells from B. abortus-infected mice, the culture supernatants contained higher levels of nitrite than those for which an unrelated antigen was used (44). This could be explained by the activating effect of IFN-gamma on NO production, but this could also be accounted for by the induction of NO by brucella LPS. The involvement of NO in the antibrucella activities of macrophages has also been suggested by pharmacological experiments with L-NMA (18), since this treatment increased significantly the number of brucellae recovered from macrophages infected with B. abortus isolated from the peritoneal cavity. However, when L-NMA was added to macrophages activated with IFN-gamma prior to the infection with brucellae, a decrease of the number of CFU was observed, thus suggesting that NO might down-regulate the production of reactive oxygen intermediates. A corollary to these findings is that reactive oxygen intermediates might play a major role in antibrucella activities, whereas NO plays a minor one. In contrast, a direct killing of B. suis by NO and an increase of the intracellular development of Brucella by iNOS inhibitors in IFN-gamma -treated J774A.1 cells infected with B. suis have been reported (17). In summary, B. abortus and B. melitensis S-LPS induce NOS in rat peritoneal macrophages. The ensuing NO production could explain why Brucella infection is controlled in mice, unlike human brucellosis, which tends to be chronic. The low Brucella S-LPS and lipid A NO production observed at low concentrations compared with LPS and lipid A E. coli induction could explain the low frequency of septic shock in human brucellosis and could contribute to explaining the long intracellular survival of Brucella.


    ACKNOWLEDGMENTS

We thank I. Moriyón, from the University of Navarra, for performing the KDO assays of LPS.

This work was supported by grants FIS 96/1017, SAF96-0144, and SAF98-0176.


    FOOTNOTES

* Corresponding author. Mailing address: IBGM, Facultad de Medicina, 47005-Valladolid, Spain. Phone: 34-983-423273. Fax: 34-983-423588. E-mail: mscres{at}ibgm.uva.es.

Editor:   E. I. Tuomanen


    REFERENCES
Top
Abstract
Text
References

1. Amura, C. R., R. Silverstein, and D. C. Morrison. 1998. Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies. Infect. Immun. 66:5372-5378[Abstract/Free Full Text].
2. Aragón, V., R. Díaz, E. Moreno, and I. Moriyón. 1996. Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide. J. Bacteriol. 178:1070-1079[Abstract/Free Full Text].
3. Baldwin, C. L., and A. J. Winter. 1994. Macrophages and Brucella. Immunol. Ser. 60:363-380[Medline].
4. Bayón, Y., A. Alonso, and M. Sánchez Crespo. 1997. Stimulation of Fcgamma receptors in rat peritoneal macrophages induces the expression of nitric oxide synthase and chemokines by mechanisms showing different sensitivities to antioxidants and nitric oxide donors. J. Immunol. 159:887-894[Abstract].
5. Berman, D. T., and R. S. Kurtz. 1987. Relationship of biological activities to structures of Brucella abortus endotoxin and LPS. Ann. Inst. Pasteur Microbiol. 138:98-101[CrossRef][Medline].
6. Canning, P. C. 1990. Phagocyte function in resistance to brucellosis, p. 151-163. In L. G. Adams (ed.), Advances in brucellosis research. Texas A&M University Press, College Station.
7. Canning, P. C., J. A. Roth, and B. L. Deyoe. 1986. Release of 5'-guanosine monophosphate and adenine by Brucella abortus and their role in the intracellular survival of the bacteria. J. Infect. Dis. 154:464-470[Medline].
8. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159[Medline].
9. Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991-1995[Abstract/Free Full Text].
10. Corbel, M. J., and W. J. Brinley-Morgan. 1984. Genus Brucella Meyer and Shaw 1920, 173AL, p. 377-388. In N. R. Krieg, and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 1. Williams & Wilkins, Baltimore, Md.
11. Díaz, R., L. M. Jones, D. Leong, and J. B. Wilson. 1968. Surface antigens of smooth brucellae. J. Bacteriol. 96:893-901[Abstract/Free Full Text].
12. Dugas, B., P. Debre, and S. Moncada. 1995. Nitric oxide, a vital poison inside the immune and inflammatory network. Res. Immunol. 146:664-670[CrossRef][Medline].
13. English, B. K., C. C. Patrick, S. L. Orlicek, R. McCordic, and J. L. Shenep. 1996. Lipoteichoic acid from viridans streptococci induces the production of tumor necrosis factor and nitric oxide by murine macrophages. J. Infect. Dis. 174:1348-1351[Medline].
14. Fang, F. C. 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Investig. 99:2818-2825[Medline].
15. Freer, E., E. Moreno, I. Moriyón, J. Pizarro-Cerdá, A. Weintraub, and J. P. Gorvel. 1996. Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts. J. Bacteriol. 178:5867-5876[Abstract/Free Full Text].
16. Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:131-138[CrossRef][Medline].
17. Gross, A., S. Spiesser, A. Terraza, B. Rouot, E. Caron, and J. Dornand. 1998. Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages. Infect. Immun. 66:1309-1316[Abstract/Free Full Text].
18. Jiang, X., B. Leonard, R. Benson, and C. L. Baldwin. 1993. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell. Immunol. 151:309-319[CrossRef][Medline].
19. Kress, S., P. Klooker, V. Kaufmann, N. Sloot, J. F. Riemann, and H. Brass. 1997. Brucellosis with fatal endotoxic shock. Med. Klin. 92:561-566[Medline].
20. Leong, D., R. Díaz, K. Milner, J. Rudbach, and J. B. Wilson. 1970. Some structural and biological properties of Brucella endotoxin. Infect. Immun. 1:174-182[Abstract/Free Full Text].
21. Lowenstein, C. J., E. W. Alley, P. Raval, A. M. Snowman, S. H. Snyder, S. W. Russell, and W. J. Murphy. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon-gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90:9730-9734[Abstract/Free Full Text].
22. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350[CrossRef][Medline].
23. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002-2012[Free Full Text].
24. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142[Medline].
25. Moreno, E., D. T. Berman, and L. A. Boettcher. 1981. Biological activities of Brucella abortus lipopolysaccharides. Infect. Immun. 31:362-370[Abstract/Free Full Text].
26. Moreno, E., M. W. Pitt, L. M. Jones, G. G. Schurig, and D. T. Berman. 1979. Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J. Bacteriol. 138:361-369[Abstract/Free Full Text].
27. Mozaffarian, N., J. W. Berman, and A. Casadevall. 1995. Immune complexes increase nitric oxide production by interferon-gamma stimulated murine macrophage-like J774.16 cells. J. Leukoc. Biol. 57:657-662[Abstract].
28. Nathan, C. 1997. Inducible nitric oxide synthase: what difference does it make? J. Clin. Investig. 100:2417-2423[Medline].
29. Nathan, C., and Q. W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918[CrossRef][Medline].
30. Orduña, A., C. Orduña, J. M. Eiros, M. A. Bratos, P. Gutiérrez, P. Alonso, and T. A. Rodríguez. 1991. Inhibition of the degranulation and myeloperoxidase activity of human polymorphonuclear neutrophils by Brucella melitensis. Microbiologia 7:113-119[Medline].
31. Parrillo, J. E. 1993. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328:1471-1477[Free Full Text].
32. Rasool, O., E. Freer, E. Moreno, and C. Jarstrand. 1992. Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils. Infect. Immun. 60:1699-1702[Abstract/Free Full Text].
33. Riley, L. K., and D. C. Robertson. 1984. Ingestion and intracellular survival of Brucella abortus in human and bovine polymorphonuclear leukocytes. Infect. Immun. 46:224-230[Abstract/Free Full Text].
34. Robertson, D. C., L. K. Riley, and D. L. Kreutzer. 1979. Intracellular survival of smooth and rough strains of Brucella, p. 150-153. In D. Schlessinger (ed.), Microbiology. American Society for Microbiology, Washington, D.C.
35. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p. 7.1-7.78. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
36. Sangari, F. J., and J. Agüero. 1996. Molecular basis of Brucella pathogenicity: an update. Microbiologia 12:207-218[Medline].
37. Schmidt, H. H., and U. Walter. 1994. NO at work. Cell 78:919-925[CrossRef][Medline].
38. Smith, L. D., and T. A. Ficht. 1990. Pathogenesis of Brucella. Crit. Rev. Microbiol. 17:209-230[Medline].
39. Stuehr, D. J., and M. A. Marletta. 1987. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma . J. Immunol. 139:518-525[Abstract].
40. Vedder, H., W. Schreiber, A. Yassouridis, S. Gudewill, C. Galanos, and T. Pollmacher. 1999. Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans. Inflamm. Res. 48:67-74[Medline].
41. Vouldoukis, I., D. Mazier, P. Debre, and M. D. Mossalayi. 1995. Nitric oxide and human infectious diseases. Res. Immunol. 146:689-692[CrossRef][Medline].
42. Weinberg, J. B., M. A. Misukonis, P. J. Shami, S. N. Mason, D. L. Sauls, W. A. Dittman, E. R. Wood, G. K. Smith, B. McDonald, and K. E. Bachus. 1995. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86:1184-1195[Abstract/Free Full Text].
43. Xie, Q. W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705-4708[Abstract/Free Full Text].
44. Zhan, Y., and C. Cheers. 1995. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect. Immun. 63:1387-1390[Abstract].
45. Zhan, Y., Z. Liu, and C. Cheers. 1996. Tumor necrosis factor-alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect. Immun. 64:2782-2786[Abstract].


Infection and Immunity, March 2000, p. 1740-1745, Vol. 68, No. 3
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Duenas, A. I., Orduna, A., Crespo, M. S., Garcia-Rodriguez, C. (2004). Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp. LPS. Int Immunol 16: 1467-1475 [Abstract] [Full Text]  
  • Ko, J., Gendron-Fitzpatrick, A., Splitter, G. A. (2002). Susceptibility of IFN Regulatory Factor-1 and IFN Consensus Sequence Binding Protein-Deficient Mice to Brucellosis. J. Immunol. 168: 2433-2440 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by López-Urrutia, L.
Right arrow Articles by Sánchez Crespo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by López-Urrutia, L.
Right arrow Articles by Sánchez Crespo, M.